News
Do frequent urges to urinate or urine leaks disrupt your life? Use Medindia’s overactive bladder calculator to assess your ...
Jacee Holton and Leah Kubiak earned third place honors at Valdosta State University’s 2025 Graduate Student Research and ...
If you have Parkinson’s disease, exercise can help improve your quality of life while boosting your mobility and strength. Learn how yoga, seated exercises, water aerobics, and more can help ...
14don MSN
Aamir Khan makes vada pav on Mumbai streets ahead of Sitaare Zameen Par release, receives standing ovation from audience at special screening Adnan Sami shares how he lost 120 kg without any surgery: ...
Treatment for Parkinson's focuses on managing its many symptoms, as there is no cure. But a new stem cell therapy developed at Memorial Sloan Kettering Cancer Center for advanced Parkinson's is ...
Potential Positives. On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson’s disease in Q4 2025, indicating significant progress in clinical development.
NEW HAVEN, Conn., May 6, 2025 /PRNewswire/ -- XingImaging, a MITRO company, a pioneer in advanced research imaging, radiopharmaceutical services, and medical imaging technology, proudly announces ...
Parkinson’s disease is a neurodegenerative disorder caused by the gradual loss of dopamine-producing cells in the brain. Commonly affecting older adults, it manifests through both motor symptoms ...
Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform. EMBO Molecular Medicine , 2025; DOI: 10.1038/s44321-025-00229-z Cite This Page : ...
A new drug is showing promise in treating Parkinson’s while reducing unwanted side effects. The pill, tavapadon, extended symptom relief without the adverse effects of the first line of treatment.
ParkinSINGS, a choir of Parkinson's patients, will sing at the stadium for the second year as part of efforts to raise awareness about the disease and its vocal symptoms.
A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results